PWPS
RCKT icon

Pinnacle Wealth Planning Services’s Rocket Pharmaceuticals RCKT Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.19K Hold
2,566
– – ﹤0.01% 2033
2025
Q4 		$9.01K Buy
+2,566
New +$8.79K ﹤0.01% 2052

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pinnacle Wealth Planning Services's RCKT Position: Q1 2026 in Review

Pinnacle Wealth Planning Services held its Rocket Pharmaceuticals (RCKT) position steady in Q1 2026 at 2,566 shares worth $9.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Pinnacle Wealth Planning Services first reported a position in RCKT in Q4 2025 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Pinnacle Wealth Planning Services held 2,566 shares of Rocket Pharmaceuticals worth $9.19K as of Q1 2026.
  • Pinnacle Wealth Planning Services left its Rocket Pharmaceuticals share count unchanged in Q1 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2033 holding.
  • Pinnacle Wealth Planning Services first reported a position in Rocket Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.